NRC — NRC HEALTH
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 70487 ·
Last close
$25.89
Market Cap
$549.32M
52W High
$27.60
52W Low
$11.45
ADV30
103,227
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 35,392,000 | 21,828,000 | -3,238,000 | -3,283,000 | 136,152,000 | 3,327,000 | 129,603,000 |
| Mar 2026 | 34,803,000 | 21,157,000 | 5,569,000 | 3,222,000 | 134,559,000 | 2,547,000 | 121,064,000 |
| Dec 2025 | 35,194,000 | 21,259,000 | 4,669,000 | 1,798,000 | 134,878,000 | 4,139,000 | 120,888,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$29,509,000
Investing CF
$-7,868,000
Financing CF
$-23,588,000
CapEx
$-7,868,000
Dividends Paid
$-12,705,000
Buybacks
$-18,848,000
EPS Diluted TTM
$0.28
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-24,507,000
Inventory
—
Receivables
$13,649,000
ST Investments
—
EBIT TTM
$14,789,000
Pretax Income TTM
$9,384,000
Interest Exp TTM
$5,405,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$143,788,000
EBITDA
$27,719,000
Free Cash Flow
$20,381,500
Enterprise Value
$648,402,944
Total Cash
$3,626,000
Total Debt
$103,240,000
Shares Out
21,221,538
Trailing EPS
$0.27
Book Value
$-0.43
ROE
248.1%
ROA
8.7%
Div Yield
2.48%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 137,390,000 | 22,590,000 | 11,600,000 | 134,878,000 | 120,888,000 | 13,990,000 | 26,450,000 |
| Dec 2024 | 143,060,000 | 35,194,000 | 24,783,000 | 132,539,000 | 101,255,000 | 31,284,000 | 34,625,000 |
| Dec 2023 | 148,580,000 | 40,045,000 | 30,971,000 | 122,437,000 | 73,482,000 | 48,955,000 | 38,113,000 |
| Dec 2022 | 151,568,000 | 46,543,000 | 31,800,000 | 130,461,000 | 58,428,000 | 72,033,000 | 36,265,000 |
TTM Snapshot
Revenues TTM
$139,996,000
NetIncome TTM
$5,858,000
OpCashFlow TTM
—
Assets (Latest)
$136,152,000
Forward EPS
$1.06
Max Pain — expiry 2026-12-18
max pain strike: $20.00 · spot: $26.16 · call oi: 1,301 · put oi: 92
Expected Move to 2026-12-18:
±$1.52
(5.81%) —
implied range
$24.64 –
$27.68
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | $530.18M | $5.54 | — |
| TKNO | Alpha Teknova, Inc. | $481.21M | $7.65 | — |
| QUIT | ACHIEVE LIFE SCIENCES, INC. | $630.99M | $6.12 | — |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $666.81M | $6.06 | — |
| QDEL | QuidelOrtho Corp | $677.21M | $9.87 | — |
News headlines (Yahoo Finance, 1h cache)
NRC Health: 3 Key Takeaways for Long-Term Investors
2026-11-08 23:35 · Yahoo
National Research: Q3 Earnings Snapshot
2026-10-28 18:34 · Yahoo
National Research Corporation Q3 2026 Earnings Call Summary
2026-10-28 00:45 · Yahoo
NRC Health (NRC) Q3 2026 Earnings Call Transcript
2026-10-27 23:02 · Yahoo
National Research Q3 Earnings Call Highlights
2026-10-27 22:04 · Yahoo
NRC Health Announces Third Quarter 2026 Results
2026-10-27 20:00 · Yahoo
New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action
2026-10-15 20:53 · Yahoo
NRC Health's Dividend Analysis
2026-09-25 11:04 · Yahoo
The Governance Institute Blue Ribbon Committee Reframes Hospital and Health System Board Assessment with Four Considerations for Stronger Governance
2026-09-21 14:45 · Yahoo
KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score
2026-09-02 19:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.